Long-Term Outcomes Following Thermal Ablation of Benign Thyroid Nodules as an Alternative to Surgery: The Importance of Controlling Regrowth
- PMID: 31257739
- PMCID: PMC6599899
- DOI: 10.3803/EnM.2019.34.2.117
Long-Term Outcomes Following Thermal Ablation of Benign Thyroid Nodules as an Alternative to Surgery: The Importance of Controlling Regrowth
Abstract
Thermal ablation (TA) procedures, such as radiofrequency ablation and laser ablation, are used for the treatment of benign thyroid nodules. Short-term studies (<2 years) have demonstrated that TA is an effective and safe procedure to improve cosmetic or symptomatic problems. However, studies including a longer follow-up period show that treated thyroid nodules can increase in size after 2 to 3 years. Several studies suggest that this results from regrowth at the undertreated nodule margins. Here, we review current data on regrowth after TA and describe factors related to it and possible approaches to prevent it.
Keywords: Ablation; Thyroid nodule.
Copyright © 2019 Korean Endocrine Society.
Conflict of interest statement
This study received no funding in the form of grants. Jung Hwan Baek's financial activities are not related to the present article (patent holder of a unidirectional ablation electrode); he has been a consultant to two radiofrequency companies, STARmed and RF Medical, since 2017.
Figures
Comment in
-
Letter: Long-Term Outcomes Following Thermal Ablation of Benign Thyroid Nodules as an Alternative to Surgery: The Importance of Controlling Regrowth (Endocrinol Metab 2019;34:117-23, Jung Suk Sim et al.).Endocrinol Metab (Seoul). 2019 Sep;34(3):323-324. doi: 10.3803/EnM.2019.34.3.323. Endocrinol Metab (Seoul). 2019. PMID: 31565885 Free PMC article. No abstract available.
-
Response: Long-Term Outcomes Following Thermal Ablation of Benign Thyroid Nodules as an Alternative to Surgery: The Importance of Controlling Regrowth (Endocrinol Metab 2019;34:117-23, Jung Suk Sim et al.).Endocrinol Metab (Seoul). 2019 Sep;34(3):325-326. doi: 10.3803/EnM.2019.34.3.325. Endocrinol Metab (Seoul). 2019. PMID: 31565886 Free PMC article. No abstract available.
References
-
- Cesareo R, Palermo A, Pasqualini V, Cianni R, Gaspa G, Manfrini S, et al. Radiofrequency ablation for the management of thyroid nodules: a critical appraisal of the literature. Clin Endocrinol (Oxf) 2017;87:639–648. - PubMed
-
- Papini E, Guglielmi R, Bizzarri G, Graziano F, Bianchini A, Brufani C, et al. Treatment of benign cold thyroid nodules: a randomized clinical trial of percutaneous laser ablation versus levothyroxine therapy or follow-up. Thyroid. 2007;17:229–235. - PubMed
-
- Deandrea M, Limone P, Basso E, Mormile A, Ragazzoni F, Gamarra E, et al. US-guided percutaneous radiofrequency thermal ablation for the treatment of solid benign hyperfunctioning or compressive thyroid nodules. Ultrasound Med Biol. 2008;34:784–791. - PubMed
-
- Pacella CM, Bizzarri G, Guglielmi R, Anelli V, Bianchini A, Crescenzi A, et al. Thyroid tissue: US-guided percutaneous interstitial laser ablation-a feasibility study. Radiology. 2000;217:673–677. - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
